In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease

In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease

Shu-Tong Huang,1,2,* Jin-Chong Luo,1,3,* Guo-Hui Zhong,1,2 Li-Ping Teng,4 Cai-Yan Yang,4 Chun-Li Tang,1 Lin Jing,1 Zhong-Bo Zhou,4 Jing Liu,1,3 Neng Jiang1,2 1Department of Pharmacy, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People’s Republic of China; 2Pharmaceut...

Full description

Bibliographic Details
Main Authors: Huang ST, Luo JC, Zhong GH, Teng LP, Yang CY, Tang CL, Jing L, Zhou ZB, Liu J, Jiang N
Format: Article
Language:English
Published: Dove Medical Press 2024-01-01
Series:Drug Design, Development and Therapy
Subjects:
alzheimer’s disease
cholinesterase
monoamine oxidase
multi-target
designed
Online Access:https://www.dovepress.com/in-vitro-and-in-vivo-biological-evaluation-of-newly-tacrine-selegiline-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/in-vitro-and-in-vivo-biological-evaluation-of-newly-tacrine-selegiline-peer-reviewed-fulltext-article-DDDT

Similar Items